US · Healthcare

Kura Oncology Inc (KURA)

Biotechnology

Kura Oncology Inc (KURA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KURA

P/E ratio

18.00

Kura Oncology Inc (KURA) — FAQ

What is KURA's P/E ratio?

The price-to-earnings (P/E) ratio for Kura Oncology Inc (KURA) is 18.00 (data as of 2026-03-24).

Does Kura Oncology Inc pay a dividend?

Dividend yield is not available in the current snapshot for Kura Oncology Inc (KURA). Check the MyAverix Finance app for the latest dividend data.

What sector is Kura Oncology Inc in?

Kura Oncology Inc (KURA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KURA listed on?

KURA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)